GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (FRA:CY9D) » Definitions » 3-Year EPS without NRI Growth Rate

Microbot Medical (FRA:CY9D) 3-Year EPS without NRI Growth Rate : 9.30% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Microbot Medical 3-Year EPS without NRI Growth Rate?

Microbot Medical's EPS without NRI for the three months ended in Mar. 2024 was €-0.16.

During the past 3 years, the average EPS without NRI Growth Rate was 9.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 45.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Microbot Medical was 87.10% per year. The lowest was -14.90% per year. And the median was 14.60% per year.


Competitive Comparison of Microbot Medical's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Microbot Medical's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Microbot Medical's 3-Year EPS without NRI Growth Rate falls into.



Microbot Medical 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Microbot Medical  (FRA:CY9D) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Microbot Medical 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Microbot Medical's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbot Medical (FRA:CY9D) Business Description

Traded in Other Exchanges
Address
25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

Microbot Medical (FRA:CY9D) Headlines

No Headlines